
AstraZeneca signs multibillion-pound agreement with Chinese biotech firm CSPC to develop AI-powered treatments in ...
In the ever-evolving world of healthcare and tech, big pharma is now looking to artificial intelligence as the next major game-changer. And AstraZeneca, the UK’s largest listed company, is putting serious money behind that vision—even if it means dealing …